Seegene

Seegene, Inc. is molecular diagnostic (MoDx) company that has been turning dreams of molecular diagnostic fields into reality through its pioneering R & D activities and novel technologies. Found in Seoul, Korea in 2000 and with having subsidiary in Rockville, MD, U.S.A., Seegene, Inc. has continued to develop innovative technology platforms, ACP™ (Annealing Control Primer), DPO™ (Dual Priming Oligonucleotide), and READ™ (Real Amplicon Detection) and stretch out globally to better respond to the needs of its valued customers. With these cutting-edge MoDx technologies applied to diagnostic kits and various practical approaches, Seegene has enhanced the sensitivity and specificity of PCR (polymerase chain reaction) up to unprecedented level. This advance enables Seegene, Inc. to provide multiplex PCR products by which multiple target genes of pathogens can be simultaneously detected, saving testing time and cost. Seegene, Inc. will continue to set new standards in MoDx and provide foundation for innovations to come.

Similar to current existing Real-time PCR platform Real-time PCR instrument (ABI 7500 / Bio-Rad CFX 96) Less multiplicity test than Magicplex

Workflow

• 96 tests
• Bio-Rad CFX96
• Real-Time PCR Instrument

Almost same test procedure as current real time PCR platforms (i.e. : Roche, Abbott, Siemens, Qiagen ….. )

For more complicated multiplicity using Real-time PCR Thermal cycler & Real time PCR instrument Solves the hurdle of current real time PCR multiplex (high number of pathogens, sensitivity, specificity & reproducibility)

• 6 tests
• Bio-Rad CFX96
• Real-Time PCR Instrument

Provides flexibility
Efficiency in SAMPLE MANAGEMENT Re-check, Re-test : Possible using amplicon bank as sample material for re-test not necessary to go to sample step again

http://www.seegene.com